Tuesday, October 18, 2011

Cancer Gene Therapy - Table of Contents alert Volume 18 Issue 11

TABLE OF CONTENTS

Volume 18, Issue 11 (November 2011)

In this issue
Original Articles

Also new
AOP

Advertisement


Can I really get the confidence I need to find genetic variants? Sure You Can, with the new Agilent SureScan Microarray Scanner. Our new compact system for cytogenetic research applications provides the resolution required to detect copy number changes or copy neutral aberrations. Click here for a special offer and to learn more.

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
CANCER GENE THERAPY
The Journal of Cancer Gene and Cellular Therapies

Submit your research and 110,000+ registered professionals in the field of cancer research and related disciplines will see your paper via the monthly Table of Content e-alerts.
 

Original Articles

Top

Effect of fractalkine-Fc delivery in experimental lung metastasis using DNA/704 nanospheres

P Richard-Fiardo, B Cambien, E Pradelli, F Beilvert, B Pitard, H Schmid-Antomarchi and A Schmid-Alliana

Cancer Gene Ther 2011 18: 761-772; advance online publication, August 26, 2011; 10.1038/cgt.2011.42

Abstract | Full Text

Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo

T J Harvey, I M Hennig, S D Shnyder, P A Cooper, N Ingram, G D Hall, P J Selby and J D Chester

Cancer Gene Ther 2011 18: 773-784; advance online publication, August 12, 2011; 10.1038/cgt.2011.43

Abstract | Full Text

Virotherapy induces massive infiltration of neutrophils in a subset of tumors defined by a strong endogenous interferon response activity

X Fu, L Tao, A Rivera, H Xu and X Zhang

Cancer Gene Ther 2011 18: 785-794; advance online publication, August 26, 2011; 10.1038/cgt.2011.46

Abstract | Full Text

Influence of osteopontin expression on the metastatic growth of CC531 rat colorectal carcinoma cells in rat liver

M E Uhlmann, R B Georges, A Boleij, E Eyol, A Kubarenko, H Adwan and M R Berger

Cancer Gene Ther 2011 18: 795-805; advance online publication, August 19, 2011; 10.1038/cgt.2011.48

Abstract | Full Text

EphrinA1 inhibits malignant mesothelioma tumor growth via let-7 microRNA-mediated repression of the RAS oncogene

N Khodayari, K A Mohammed, E P Goldberg and N Nasreen

Cancer Gene Ther 2011 18: 806-816; advance online publication, August 26, 2011; 10.1038/cgt.2011.50

Abstract | Full Text

Therapeutic targeting of subdural medulloblastomas using human neural stem cells expressing carboxylesterase

S-H Lim, S A Choi, J Y Lee, K-C Wang, J H Phi, D-H Lee, S H Song, J H Song, X Jin, H Kim, H J Lee, I Lim, S U Kim and S-K Kim

Cancer Gene Ther 2011 18: 817-824; advance online publication, August 26, 2011; 10.1038/cgt.2011.52

Abstract | Full Text

Oncolytic adenovirus armed with human papillomavirus E2 gene in combination with radiation demonstrates synergistic enhancements of antitumor efficacy

W Wang, X Xia, S Wang, N Sima, Y Li, Z Han, Q Gao, A Luo, K Li, L Meng, J Zhou, C Wang, K Shen and D Ma

Cancer Gene Ther 2011 18: 825-836; advance online publication, August 19, 2011; 10.1038/cgt.2011.53

Abstract | Full Text

Advertisement
Nature Reviews Genetics
POSTER Tools for studying and using small RNAs: from pathways to functions to therapies

Authors: Kenneth Chang and Gregory J. Hannon
November 2011

Access the Poster FREE online!
www.nature.com/nrg/posters/small-RNA

COMING SOON: RNA interference animation

Produced with support from
Thermo Scientific
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: